Gilead Sciences, Inc. has joined forces with Unite for HER (UFH) to introduce the Metastatic Breast Cancer Sustainer Program, a groundbreaking initiative aimed at providing free integrative care to Black, Hispanic, and underserved metastatic breast cancer patients across the United States. This program offers a range of services including acupuncture, professional counseling, personalized nutrition support, and fitness memberships, all at no cost to the patients.

Sue Weldon, Founder and CEO of Unite for HER, emphasized the program’s impact, stating it has become a crucial support system for members, particularly those from marginalized communities. The initiative not only aims to improve the quality of life for these patients but also to ensure they remain on their treatment paths by addressing their holistic needs.

Carmen Villar, Senior Vice President of Global Giving, Advocacy, and Responsibility at Gilead Sciences, highlighted the company’s commitment to innovative solutions that cater to the metastatic breast cancer community’s unique needs. This partnership underscores Gilead’s dedication to making a tangible difference in the lives of patients through accessible and comprehensive care.

Since its inception in October 2023, the program has already supported over 2,823 metastatic breast cancer patients. With Gilead Sciences’ funding, a new focus has been placed on aiding Black, Hispanic, and underserved populations, furthering the program’s reach and impact. For more information on the program and Unite for HER’s services, visit https://www.uniteforher.org.

This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Gilead Sciences and Unite for HER Launch Program to Support Metastatic Breast Cancer Patients.